Loading...

About UK NEQAS

UK NEQAS for Immunocytochemistry & In-Situ-Hybridisation (UK NEQAS ICC & ISH)

UK NEQAS ICC & ISH provides an international external quality assessment and technical advice/education service to laboratories throughout the world. The Scheme was founded in 1985 by Mr Gerry Reynolds at Mount Vernon Hospital, Middlesex. At that time its participant-base comprised approximately 20 laboratories based predomininetly in and around London. Since that time it has grown into an international organisation serving over 500 laboratories and operating in more than 50 countries.

UK NEQAS ICC & ISH is hosted by External Quality Assessment Services for Cancer Diagnostics CIC; a not-for-profit Community Interest Company limited by guarantee registered in England and Wales (Companies House Registration: 10585826).

All UK NEQAS designated schemes are members of the UK NEQAS Charity, a not-for-profit registered charity.

The UK NEQAS Charity

UK NEQAS is a world leader in External Quality Assessment, improving the quality of diagnostic testing. Education is at the heart of all our EQA services as we share our expertise in partnership with our users, industry and professional bodies globally.

With UK NEQAS you have access to the very best training and support, worldwide, and are compared to the best, by the best.

Our Mission Statement

To improve global diagnostic testing through quality assessment and education.